(II) 与非类固醇抗炎药物的复合物:结构和生物活性
Filitsa Dimiza1, Antonios G Hatzidimitriou1, George Psomas1
1Department of General and Inorganic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece.
International journal of molecular sciences
|January 8, 2025
概括
新的 ((II) 复合物与抗炎药物显示出有前途的抗氧化和DNA结合性质. 这些金属复合物与DNA和血清白蛋白相互作用,提供潜在的治疗应用.
科学领域:
- 协调化学 协调化学
- 药用无机化学 药用无机化学
- 药物发现 药物发现 药物发现
背景情况:
- 非类固醇抗炎药物 (NSAIDs) 广泛用于治疗疼痛和炎症.
- 复合物可以表现出独特的生物活动.
- 研究金属药物复合体可以导致新型治疗剂.
研究的目的:
- 合成和表征新型 (II) 复合物,其中包含NSAIDs.
- 评估这些复合物的生物特征,重点关注抗氧化活性和生物分子相互作用.
- 探索这些金属药物合物的潜在治疗应用.
主要方法:
- 合成 (II) 复合物与各种NSAIDs和捐赠者辅配体.
- 使用光谱技术和单晶X射线晶体学进行了表征.
- 通过自由基清除试验 (ABTS试验) 评估抗氧化剂活性.
- 研究与小牛胸腺DNA和血清白蛋白的相互作用.
主要成果:
- 九个 (II) 复合物已成功准备并进行结构性特征.
- 综合体显示了与小牛胸腺DNA的间接结合.
- 观察到与人类和牛血清白蛋白的紧密和可逆结合.
- 这些复合物通过清除ABTS自由基,表现出显著的抗氧化活性.
结论:
- 合成的 ((II) -NSAID复合物具有有利的DNA和血清白蛋白结合能力.
- 这些复合物表现出显著的抗氧化特性,表明潜在的治疗益处.
- 对这些金属复合物的进一步研究可能会为新的抗炎和抗氧化剂铺平道路.
相关概念视频
Structure-Activity Relationships and Drug Design
494
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
494
Combined Effects of Drugs: Antagonism
8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
516
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
516
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
342
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
342
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K


